- Moral Standards for Research in Developing Countries from "Reasonable Availability" to "Fair Benefits".Maged El Setouhy, Tsiri Agbenyega, Francis Anto, Christine Alexandra Clerk, Kwadwo A. Koram, Michael English, Rashid Juma, Catherine Molyneux, Norbert Peshu, Newton Kumwenda, Joseph Mfutso-Bengu, Malcolm Molyneux, Terrie Taylor, Doumbia Aissata Diarra, Saibou Maiga, Mamadou Sylla, Dione Youssouf, Catherine Olufunke Falade, Segun Gbadegesin, Reidar Lie, Ferdinand Mugusi, David Ngassapa, Julius Ecuru, Ambrose Talisuna, Ezekiel Emanuel, Christine Grady, Elizabeth Higgs, Christopher Plowe, Jeremy Sugarman & David Wendler - 2004 - Hastings Center Report 34 (3):17.details
|
|
The 50th Anniversary of the Declaration of Helsinki: Progress but Many Remaining Challenges.J. Millum - 2013 - Journal of the American Medical Association 310 (20):2143-44.details
|
|
Post‐trial obligations in the Declaration of Helsinki 2013: classification, reconstruction and interpretation.Ignacio Mastroleo - 2016 - Developing World Bioethics 16 (2):80-90.details
|
|
Post-trial access to treatment: corporate best practices.Irene Schipper & Silvia Colona - 2015 - SOMO Centre for Research on Multinational Corporations.details
|
|
Ensuring Access to HIV Prevention Services in South African HIV Vaccine Trials: Correspondence Between Guidelines and Practices.Zaynab Essack - 2014 - Public Health Ethics 7 (2):195-206.details
|
|
(1 other version)Ethics in practice: the state of the debate on promoting the social value of global health research in resource poor settings particularly Africa.Geoffrey M. Lairumbi, Michael Parker, Raymond Fitzpatrick & Michael C. English - 2011 - BMC Medical Ethics 12 (1):22.details
|
|
Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review.N. Sofaer & D. Strech - 2011 - Public Health Ethics 4 (2):160-184.details
|
|
Because we can: Clashes of perspective over researcher obligation in the failed prep trials.Bridget G. Haire - 2011 - Developing World Bioethics 11 (2):63-74.details
|
|
Human Dignity and Human Rights as a Common Ground for a Global Bioethics.R. Andorno - 2009 - Journal of Medicine and Philosophy 34 (3):223-240.details
|
|
Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma.David B. Resnik - 2001 - Developing World Bioethics 1 (1):11-32.details
|
|
Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in western Kenya.D. N. Shaffer - 2006 - Journal of Medical Ethics 32 (1):55-60.details
|
|
Vulnerability: Too Vague and Too Broad?Doris Schroeder & Eugenijus Gefenas - 2009 - Cambridge Quarterly of Healthcare Ethics 18 (2):113.details
|
|
Bioethics and the question of human dignity.Adam Schulman - 2008 - In Human dignity and bioethics: essays commissioned by the President's Council on Bioethics. Washington, D.C.: [President's Council on Bioethics.details
|
|
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.details
|
|
(1 other version)Justice and the human development approach to international research.Alex John London - 2005 - Hastings Center Report 35 (1):24-37.details
|
|
Legal and Ethical Regulation of Biomedical Research in Developing Countries.Remigius N. Nwabueze - 2013 - Routledge.details
|
|
Post‐Trial Access to Antiretrovirals: Who Owes What to Whom?Joseph Millum - 2011 - Bioethics 25 (3):145-154.details
|
|
Attitudes toward Post‐Trial Access to Medical Interventions: A Review of Academic Literature, Legislation, and International Guidelines. [REVIEW]Kori Cook, Jeremy Snyder & John Calvert - 2015 - Developing World Bioethics 16 (2):70-79.details
|
|
(1 other version)Research Bioethics in the Ugandan Context II: Procedural and Substantive Reform.Sana Loue & David Okello - 2000 - Journal of Law, Medicine and Ethics 28 (2):165-173.details
|
|
Reciprocity‐Based Reasons for Benefiting Research Participants: Most Fail, the Most Plausible is Problematic.Neema Sofaer - 2013 - Bioethics 28 (9):456-471.details
|
|
Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare.Neema Sofaer, Penney Lewis & Hugh Davies - 2014 - Journal of Medical Ethics 40 (4):217-218.details
|
|
(1 other version)Taking Benefits Seriously in Developing Countries.Leonard H. Glantz, George J. Annas, Michael A. Grodin & Wendy K. Mariner - 1998 - Hastings Center Report 28 (6):38-42.details
|
|
Mind the gap: An empirical study of post‐trial access in HIV biomedical prevention trials.Bridget Haire & Christopher Jordens - 2013 - Developing World Bioethics 15 (2):85-97.details
|
|
Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?Z. Zong - 2008 - Journal of Medical Ethics 34 (3):188-192.details
|
|
Protecting communities in health research from exploitation.Segun Gbadegesin & David Wendler - 2006 - Bioethics 20 (5):248-253.details
|
|
(1 other version)Pharmaceutical Companies vs. the State: Who is Responsible for Post-Trial Provision of Drugs in Brazil?Daniel Wei L. Wang & Octavio Luiz Motta Ferraz - 2012 - Journal of Law, Medicine and Ethics 40 (2):188-196.details
|
|
(1 other version)International Research and Just Sharing of Benefits in Mexico.Javier E. GarcÍa De Alba Ricardo PÁez - 2009 - Developing World Bioethics 9 (2):65-73.details
|
|
Solidaroty and equity : new ethical frameworks for genetic databases.Ruth Chadwick & Kåre Berg - 2001 - .details
|
|
Responsibilities in international research: a new look revisited.S. R. Benatar & P. A. Singer - 2010 - Journal of Medical Ethics 36 (4):194-197.details
|
|
(1 other version)Justice and the Human Development Approach to International Research.Alex John London - 2005 - Hastings Center Report 35 (1):24.details
|
|
Ethics of medical care and clinical research: a qualitative study of principal investigators in biomedical HIV prevention research.Bridget G. Haire - 2013 - Journal of Medical Ethics 39 (4):231-235.details
|
|
Mapping African ethical review committee activity onto capacity needs: The Marc initiative and hrweb's interactive database of recs in Africa.Carel Ijsselmuiden, Debbie Marais, Douglas Wassenaar & Boitumelo Mokgatla-Moipolai - 2012 - Developing World Bioethics 12 (2):74-86.details
|
|
Justice in international clinical research.Bridget Pratt & Bebe Loff - 2010 - Developing World Bioethics 11 (2):75-81.details
|
|
HIV prevention research and global inequality: steps towards improved standards of care.K. Shapiro - 2005 - Journal of Medical Ethics 31 (1):39-47.details
|
|
Stakeholder perspectives on ethical challenges in hiv vaccine trials in south Africa.Zaynab Essack, Jennifer Koen, Nicola Barsdorf, Catherine Slack, Michael Quayle, Cecilia Milford, Graham Lindegger, Chitra Ranchod & Richard Mukuka - 2009 - Developing World Bioethics 10 (1):11-21.details
|
|
Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?Daniel Wei Wang & Octavio Motta Ferraz - 2012 - Journal of Law, Medicine and Ethics 40 (2):188-196.details
|
|
(1 other version)Realizing benefit sharing - the case of post-study obligations.Doris Schroeder & Eugenijus Gefenas - 2012 - Bioethics 26 (6):305-314.details
|
|
(1 other version)The Balm of Gilead: Is the Provision of Treatment to Those Who Seroconvert in HIV Prevention Trials a Matter of Moral Obligation or Moral Negotiation?Charles Weijer & Guy J. LeBlanc - 2006 - Journal of Law, Medicine and Ethics 34 (4):793-808.details
|
|
(1 other version)The Balm of Gilead: Is the Provision of Treatment to those Who Seroconvert in HIV Prevention Trials a Matter of Moral Obligation or Moral Negotiation?Charles Weijer & Guy J. LeBlanc - 2006 - Journal of Law, Medicine and Ethics 34 (4):793-808.details
|
|
(1 other version)Realizing benefit sharing – the case of post-study obligations.Doris Schroeder & Eugenijus Gefenas - 2011 - Bioethics 26 (6):305-314.details
|
|
Hiv international clinical research: Exploitation and risk.Angela Ballantyne - 2005 - Bioethics 19 (5-6):476-491.details
|
|
The HIV/aIDS pandemic: A sign of instability in a complex global system.Solomon R. Benatar - 2002 - Journal of Medicine and Philosophy 27 (2):163 – 177.details
|
|
(1 other version)'Due' and 'Undue' Inducements: On Pasing Money to Research Subjects.Ruth Macklin - 1981 - IRB: Ethics & Human Research 3 (5):1.details
|
|
Donating Human Samples: Who Benefits? – Cases from Iceland, Kenya, and Indonesia.J. Lucas, D. Schroeder, G. Arnason, P. Andanda, J. Kimani, V. Fournier & M. Krishnamurthy - 2013 - In Doris Schroeder & Julie Cook Lucas (eds.), Benefit Sharing – From Biodiversity to Human Genetics. Dordrecht, Netherlands: Springer.details
|
|
Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: A systematic survey of registered trials.Emma R. M. Cohen, Jennifer M. O'neill, Michel Joffres, Ross E. G. Upshur & Edward Mills - 2008 - Developing World Bioethics 9 (2):74-80.details
|
|
Engaging Diverse Social and Cultural Worlds: Perspectives on Benefits in International Clinical Research From South African Communities.Olga Zvonareva, Nora Engel, Eleanor Ross, Ron Berghmans, Ames Dhai & Anja Krumeich - 2013 - Developing World Bioethics 15 (1):8-17.details
|
|
(1 other version)Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?Daniel Wei L. Wang & Octavio Luiz Motta Ferraz - 2012 - Journal of Law, Medicine and Ethics 40 (2):188-196.details
|
|
Ethics committees for biomedical research in some African emerging countries: which establishment for which independence? A comparison with the USA and Canada.J. -P. Rwabihama, C. Girre & A. -M. Duguet - 2010 - Journal of Medical Ethics 36 (4):243-249.details
|
|
Is Ethical Research Feasible in Developed and Developing Countries?Carlos Del R.Ío - 2002 - Bioethics 12 (4):328-330.details
|
|
Article 6 of the Unesco Universal declaration of bio-ethics and human rights: A moral force in South Africa.Riaan Rheeder - 2014 - South African Journal of Bioethics and Law 7 (2):51.details
|
|